Dr. John Benjamin Bond III, MD

Dr. Bond practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.

Dr. Bond's NPI, 1790757078, was assigned on February 2, 2006. Dr. Bond graduated from Vanderbilt University School Of Medicine in 1984. Dr. Bond holds Tennessee license MD0000019492.

Dr. Bond's primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.

Dr. Bond's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. Bond to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bond practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Bond's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Bond is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Bond's licenses on file in 2 states: Tennessee and Alabama.

Dmand AI lists cataract, conjunctivitis, dry eye, eyelid inflammation, glaucoma, hereditary corneal conditions, inflammation of iris and vision problems among the conditions Dr. Bond treats.

CMS data shows 668 Medicare services from Dr. Bond across 8 procedure codes in 2024, for 317 Medicare patients. Medicare paid $24,934 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 317 Medicare patients who saw Dr. Bond in 2024. The largest group is 65 to 74, with 132 patients. 74% of them have high blood pressure, and 74% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bond's median patient age at 68, with 65% women.

In 2024, Dr. Bond wrote 222 Medicare Part D claims for 58 patients. 76% of them were for generic drugs. CMS names the drug for 176 of them, across 4 drugs with 11 or more claims each, at $18,241 in total drug cost. In 2023, CMS named 205 claims across 6 drugs.

Dr. Bond accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Bond in 2020. 2020 was the busiest year, with 2. The most frequent topics are Candidemia, Candida and COVID-19. Dr. Bond's most frequent co-authors are John B. Bond, MD, Mark Philip Breazzano, MD and Srilaxmi Bearelly, MD.

CMS Open Payments shows 2 general payments to Dr. Bond from 2 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Catalyst Pharmaceuticals, Inc. paid the most, $62.

Dmand AI lists 2 awards for Dr. Bond.

Dr. Bond graduated from Vanderbilt University School Of Medicine in 1984. Dr. Bond is a member of AAO.

Dr. Bond is in network with 15 carriers, including Aetna, Cigna and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.